I agree 100%, the previous post was the Best post of the year on this message board......so good that I tweeted the Doctor's comments to AF on twitter to see if he changes his mind considering now its the Head of Neurosurgery of a respected University and hospital in Japan VS Adam's Political Science background that he studied in college !!
Are people going to believe AF or Dr. Houkin ???
I think I will bet my money on what the doctor thinks instead of what AF thinks !!
For All in agreement.....Can I get a Amen ??!!!
"Currently available treatments such as tPA and mechanical thrombectomy must be administered within the first several hours after the stroke occurs, limiting treatment to a small percentage of patients, and such interventions may also pose certain risks,” observed Dr. Kiyohiro Houkin, Chairman and Professor of Neurosurgery of Hokkaido University Medical School, and President of Hokkaido University Hospital. “The recently conducted international clinical study by Athersys in the U.S. and the U.K. suggests that intravenous administration of MultiStem within 36 hours of the occurrence of a stroke is safe, well-tolerated, and is a beneficial and effective treatment. The off-the-shelf administration of the product could be a simple and universal approach for treating acute stroke patients. Furthermore, it could be administered to patients that do not arrive at the hospital in time to receive current standard of care, or alternatively could be administered in addition to tPA or mechanical reperfusion, potentially enhancing outcomes for patients that have suffered significant strokes. If efficacy is confirmed in additional studies it is possible that this therapy could become the new standard of care for treating stroke,” concluded